Iran's 3rd-Generation COVID-19 Vaccine to Undergo Human Trial Soon
TEHRAN (FNA)- Iran's third-generation anti-COVID-19 vaccine with a new formula will undergo human trial in less than two months, Head of Tehran's Baqiyatallah University of Medical Sciences Hassan Abolqassemi announced.
"This technological product is on its animal test and has achieved good success," Abolqassemi said.
He pointed out that Vaccines with new composition known as pathogens are manufactured upon the inactivated vaccine or killed vaccine.
In a relevant development on December 29, Imam Khomeini's Order Executive Office conducted human trial of the COVID-19 vaccine by injecting the vaccine to the first volunteer at the first phase.
The World Health Organization spokesperson reacted to human trial of the Iranian domestic vaccine to combat COVID-19 vaccine by saying, "WHO welcomes all vaccine development programs around the world."
Tarik Jasarevic said in a written statement that "this is a proof of concept, the demonstration that we can indeed develop vaccines to fight this infection, that we have tools that will help us end the pandemic".